Diagnosis, treatment, and prognosis of primary intraocular lymphoma: Single‐center real‐world clinical experience

Diagnosis, treatment, and prognosis of primary intraocular lymphoma: Single‐center real‐world clinical experience

Abstract Background The diagnosis and management of primary intraocular lymphoma (PIOL) remain challenging. This study identified factors indicative of PIOL, described treatment outcomes, and determined modalities to prevent relapse. Methods We included 21 PIOL‐diagnosed patients, seven via cytology...

Full description

Bibliographic Details
Main Authors:	Gi‐June Min, Tong Yoon Kim, Young‐Woo Jeon, Joo Hyun O, Byung‐Ock Choi, Gyeongsin Park, Young‐Hoon Park, Seok‐Goo Cho
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	Cancer Medicine
Subjects:	CNS relapse local intravitreal methotrexate primary intraocular lymphoma systemic high‐dose methotrexate
Online Access:	https://doi.org/10.1002/cam4.5567

Similar Items

Clinical outcomes of intravitreal methotrexate injection protocol with a reduced initial frequency for intraocular lymphoma
by: Chiung-Ju Hsu, et al.
Published: (2022-01-01)

Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis
by: Patrij, Katrin, et al.
Published: (2011-01-01)

Electrophysiological Monitoring of Focal and Entire Retinal Function during Treatment with Intravitreal Methotrexate for Intraocular Lymphoma
by: Takashi Matsushima, et al.
Published: (2021-04-01)

Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia
by: Matteo Pederzolli, et al.
Published: (2022-08-01)

A masquerader: A report of rapid progressive primary intraocular lymphoma
by: Siti Hajar Mat Abu, et al.
Published: (2013-01-01)

Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study
by: Lauren R. Schaff, et al.
Published: (2022-01-01)

Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell LYMPHOMA: A multi-institution retrospective analysis and systematic review
by: John Xie, et al.
Published: (2021-01-01)

Real-time intracranial pressure monitoring during high-dose methotrexate treatment for primary central nervous system lymphoma
by: Antonio Dono, et al.
Published: (2020-01-01)

Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis
by: Sabine Seidel, et al.
Published: (2023-02-01)

Clinical Outcomes of RTOG 9310 Protocol for Primary Central Nervous System Lymphoma: Single-Center Experience with 87 Patients
by: Jinuk Kim, et al.
Published: (2021-11-01)

Methotrexate induced lung injury in a patient with primary CNS lymphoma: A case report
by: puneet chhabra, et al.
Published: (2012-04-01)

Methotrexate induced lung injury in a patient with primary CNS lymphoma : A case report
by: puneet chhabra, et al.
Published: (2012-01-01)

Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
by: Casey L. Anthony, et al.
Published: (2021-12-01)

Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy
by: Kebir Sied, et al.
Published: (2012-12-01)

Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma
by: Chieh‐Lung Cheng, et al.
Published: (2023-04-01)

Highly suspected primary intraocular lymphoma in a patient with rheumatoid arthritis treated with etanercept: a case report
by: Woo Keun Song, et al.
Published: (2018-06-01)

Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients
by: Xian Zhou, et al.
Published: (2020-05-01)

Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate
by: Tingting Jiang, et al.
Published: (2022-09-01)

Treatment of central nervous system lymphoma — literature review and own experiences
by: S. V. Minenko, et al.
Published: (2014-07-01)

Treatment of central nervous system lymphoma — literature review and own experiences
by: S. V. Minenko, et al.
Published: (2014-07-01)

Clinical utility of cytokine analysis in the diagnosis and efficacy monitoring of vitreoretinal lymphoma
by: Hao Kang, et al.
Published: (2022-12-01)

Intravitreal Methotrexate
by: Fatemeh Abdi, et al.
Published: (2021-10-01)

Multimodal imaging in a case of presumed secondary vitreoretinal lymphoma presenting with inner retina and optic nerve head infiltration
by: Emily S. Levine, et al.
Published: (2024-06-01)

Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alternating with Anthracycline Based Chemoimmunotherapy
by: Wang J, et al.
Published: (2022-05-01)

Lenalidomide and Rituximab Regimen Combined With Intravitreal Methotrexate Followed by Lenalidomide Maintenance for Primary Vitreoretinal Lymphoma: A Prospective Phase II Study
by: Yan Zhang, et al.
Published: (2021-06-01)

Intrathecal chemotherapy for the management of lymphoblastic lymphoma in a 4-year-old dog: a case report
by: Filipa Louise Simões Lyseight, et al.
Published: (2023-09-01)

Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry
by: Heidi Mocikova, et al.
Published: (2022-05-01)

Treatment results of modified BFM protocol in pediatric high-risk Burkitt lymphoma
by: Sema Vural, et al.
Published: (2021-08-01)

Primary Vitreoretinal Lymphoma Masquerading as Refractory Retinitis
by: Ofira Zloto, et al.
Published: (2015-10-01)

Central Nervous System Prophylaxis Utilization in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Within a Large Community Health System
by: Michael J. Williams, et al.
Published: (2024-07-01)

Genetic polymorphisms as predictors of methotrexate toxicity: literature review
by: G. A. Radzhabova, et al.
Published: (2024-04-01)

Charcoal Hemoperfusion for Methotrexate Toxicity: A Safe and Effective Life-Rescue Alternative When Glucarpidase Is Not Available
by: Alejandra Rosales, et al.
Published: (2021-08-01)

Curious case of bilateral non-resolving vitritis - Unmasking the masquerade on ultra-widefield imaging
by: Kushal Delhiwala
Published: (2022-01-01)

CD5-Positive Primary Intraocular B-Cell Lymphoma Arising during Methotrexate and Tumor Necrosis Factor Inhibitor Treatment
by: Kenji Nagata, et al.
Published: (2015-09-01)

Multiply Relapsed Secondary CNS Non-Germinal Center Diffuse Large B-Cell Lymphoma Successfully Treated with CNS-Centric Therapy
by: Fournier LL, et al.
Published: (2023-08-01)

Management of noninfectious posterior uveitis with intravitreal drug therapy
by: Tan HY, et al.
Published: (2016-10-01)

Tolerability and Efficacy of Multiple Series of Intravitreal Methotrexate Injections for Complex Retinal Detachment Associated with Proliferative Vitreoretinopathy
by: Tessnim R. Ahmad, et al.
Published: (2023-04-01)

Analysis of Key Factors Associated with Response to Salvage High-Dose Methotrexate Rechallenge in Primary Central Nervous System Lymphoma with First Relapse
by: Peng Du, et al.
Published: (2022-09-01)

Cutaneous Methotrexate-Related Epstein–Barr Virus-Positive Diffuse Large B-Cell Lymphoma in a Patient with Granulomatous Cutaneous T-Cell Lymphoma: A Case Report and Literature Review
by: Kositkuljorn C, et al.
Published: (2023-08-01)

Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma
by: Bernard Ji Guang Chua, et al.
Published: (2024-01-01)